You won't be able to get Attendance Allowance if you already get PIP or Disability Living Allowance (DLA) to pay for your ...
The EMA recommendation comes after a phase 3 randomized, double-blind, placebo-controlled clinical trial which involved 1721 patients aged 12 and older. Patients were treated with either 10 mg or 25 ...
If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback